Liquid Biopsy Market Global Trends, Market Share, Industry Size, Growth, Opportunities and Market Forecast – 2021 to 2027

The Global Liquid Biopsy Market size is expected to reach USD 19.35 billion by 2027, registering a CAGR of 13% during the forecast period 2021-2027.

Liquid biopsy is a convenient, fast, non-invasive and reproducible sampling method that can reflect changes in oncogene expression profiles and can provide a strong basis for individualized treatment and early diagnosis of cancer. In addition, recent focus has been on early cancer screening, tumor progression monitoring, treatment response and clinical prognosis evaluation, and detection of relapsed and refractory tumors. In addition, liquid biopsy has recently attracted widespread attention as a non-invasive alternative to tissue biopsy of cancer patients due to technological advances in both feasibility and time required.

Market Segments

By Technology

• Multi-gene Parallel Analysis using NGS
• Single-gene Analysis using PCR Microarrays

By Clinical Application

• Early Cancer Screening
• Therapy Selection
• Treatment Monitoring
• Recurrence Monitoring

By End User

• Reference Laboratories
• Hospitals and Physician Laboratories
• Academic & Research Centers
• Other End Users

Key Players

Prominent players operating in the global liquid biopsy market include Bio-Rad Laboratories, Inc, Biocept Inc., Guardant Health Inc., Illumina, Inc., F. Hoffmann-La Roche Ltd. (FOUNDATION MEDICINE, INC.), Johnson & Johnson, Laboratory Corporation of America Holdings, MDxHealth SA, QIAGEN N.V., and Thermo Fisher Scientific Inc.

Scope of the Report

The research study analyzes the global Liquid Biopsy industry from 360-degree analysis of the market thoroughly delivering insights into the market for better business decisions, considering multiple aspects some of which are listed below as:

Recent Developments

o Market Overview and growth analysis
o Import and Export Overview
o Volume Analysis
o Current Market Trends and Future Outlook
o Market Opportunistic and Attractive Investment Segment

Geographic Coverage

o North America Market Size and/or Volume
o Latin America Market Size and/or Volume
o Europe Market Size and/or Volume
o Asia-Pacific Market Size and/or Volume
o Rest of the world Market Size and/or Volume

Key Questions Answered by Liquid Biopsy Market Report

1. What was the Liquid Biopsy Market size in 2019 and 2020; what are the estimated growth trends and market forecast (2021-2027).

2. What will be the CAGR of the Liquid Biopsy Market during the forecast period (2021-2027)?
3. Which segments (product type/applications/end-user) were most attractive for investments in 2021? How these segments are expected to grow during the forecast period (2021-2027).
4. Which manufacturer/vendor/players in the Liquid Biopsy Market was the market leader in 2020?
5. Overview on the existing product portfolio, products in the pipeline, and strategic initiatives taken by key vendors in the market.